These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15353483)

  • 21. Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).
    Caballero OL; Resto V; Patturajan M; Meerzaman D; Guo MZ; Engles J; Yochem R; Ratovitski E; Sidransky D; Jen J
    Oncogene; 2002 May; 21(19):3003-10. PubMed ID: 12082530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
    Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A; Ikeda N; Sho M; Tomoda K; Kanehiro H; Hisanaga M; Tsurui Y; Tsutsumi M; Kato JY; Nakajima Y
    Oncol Rep; 2004 Feb; 11(2):277-84. PubMed ID: 14719054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
    Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ
    Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.
    Zhang JH; He YL; Zhu R; Du W; Xiao JH
    Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The COP9 signalosome regulates Skp2 levels and proliferation of human cells.
    Denti S; Fernandez-Sanchez ME; Rogge L; Bianchi E
    J Biol Chem; 2006 Oct; 281(43):32188-96. PubMed ID: 16943200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adhesion to fibronectin induces p27(Kip1) nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells.
    Fei M; Hang Q; Hou S; He S; Ruan C
    Mol Cell Biochem; 2014 Jan; 386(1-2):177-87. PubMed ID: 24170542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
    Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
    Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100A7, Jab1, and p27
    Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
    J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity.
    Jiang Y; Zhao RC; Verfaillie CM
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10538-43. PubMed ID: 10973491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of the stress protein p8 with Jab1 is required for Jab1-dependent p27 nuclear-to-cytoplasm translocation.
    Malicet C; Hoffmeister A; Moreno S; Closa D; Dagorn JC; Vasseur S; Iovanna JL
    Biochem Biophys Res Commun; 2006 Jan; 339(1):284-9. PubMed ID: 16300740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector.
    Sengupta A; Banerjee D; Chandra S; Banerjee S
    J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Cop9 signalosome activity by the EF-hand Ca2+-binding protein tescalcin.
    Levay K; Slepak VZ
    J Cell Sci; 2014 Jun; 127(Pt 11):2448-59. PubMed ID: 24659803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
    Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
    Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome.
    Pandey P; Siddiqui MH; Behari A; Kapoor VK; Mishra K; Sayyed U; Tiwari RK; Shekh R; Bajpai P
    Anticancer Agents Med Chem; 2019; 19(16):2019-2033. PubMed ID: 31345154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.